Nektar Therapeutics (NKTR) EBT Margin Growth (5y) (2015 - 2026)
Nektar Therapeutics (NKTR) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nektar Therapeutics | 2.04 Bn | 1.48 Bn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,288.00 |
| Dec 31, 2025 | 33,987.00 |
| Sep 30, 2025 | 6,445.00 |
| Jun 30, 2025 | -18,905.00 |
| Mar 31, 2025 | -16,953.00 |
| Dec 31, 2024 | 35,442.00 |
| Sep 30, 2024 | 18,350.00 |
| Jun 30, 2024 | 24,987.00 |
| Mar 31, 2024 | 25,318.00 |
| Dec 31, 2023 | 7,492.00 |
| Sep 30, 2023 | 15,945.00 |
| Jun 30, 2023 | -33,929.00 |
| Mar 31, 2023 | -38,354.00 |
| Dec 31, 2022 | -22,151.00 |
| Jun 30, 2022 | -56,367.00 |
| Mar 31, 2022 | -10,592.00 |
| Dec 31, 2021 | 163,340.00 |
| Sep 30, 2021 | -22,688.00 |
| Jun 30, 2021 | -6,505.00 |
| Mar 31, 2021 | -48,679.00 |